What Atys Medical does

Atys Medical is a privately held French medical device manufacturer, headquartered in Soucieu-en-Jarrest, that designs, develops, manufactures, markets, and sells non-invasive diagnostic devices. Founded in 1985 and operating with a staff of 11–50, the company specializes in ultrasound Doppler technology applied to vascular and cerebral blood flow assessment, including transcranial Doppler, vascular Doppler, photoplethysmography (PPG), and pneumoplethysmography (PVR). Its product family includes ANGIOLYS (premium peripheral vascular testing system), BASIC (routine vascular diagnostic line), MICROFLOW S (pocket Doppler), SYSTOE/SysToe (toe and finger systolic pressure measurement with a patented PPG algorithm), WAKIe (digital portable TCD with robotic probes), TCD-X (ambulatory TCD Holter developed with Dr. Rune Aaslid), WAKIe TO (oesophageal Doppler cardiac output monitor with reusable probes), and OptiMAP (cerebral autoregulation research software).

The company serves healthcare professionals across multiple specialties: angiologists and vascular specialists, neurologists and neurovascular specialists, diabetologists and diabetic foot care centres, nephrologists, anaesthesia and intensive care professionals, and clinical researchers. Customer segments are organized horizontally by clinical use case rather than vertically by buyer type. Its pricing is quote-based and not publicly disclosed, and all sales are executed through a direct sales motion supported by website contact forms and conference presence, with multi-year contract cadences typical for capital medical equipment. The company claims worldwide distribution and clinical validation through a 200-patient study at Nimes University Hospital published in the European Journal of Vascular and Endovascular Surgery.

Atys Medical operates a single-site manufacturing model in France with hardware sales as its primary revenue mechanism, supplemented by reusable probe recurring sales and research software. It is privately held with no disclosed institutional investors, no funding rounds, no M&A activity, and no public financial filings. Strategic activity over the past two decades has been characterized by incremental product innovation within its core Doppler-based portfolio rather than by acquisitions, capital raises, or geographic entries.

Name

Atys Medical

Legal name

Atys Medical

Website

https://atysmedical.com

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

11–50 employees

Short description

Atys Medical is a privately held French manufacturer founded in 1985 that designs, builds, and sells non-invasive ultrasound Doppler diagnostic devices — including transcranial Doppler, vascular testing systems, and toe-pressure measurement tools — serving angiologists, neurologists, diabetologists, ICUs, and clinical researchers worldwide through direct quote-based sales.

Ownership category

akta.pro rank

Product category

Vascular Diagnostic Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)

akta.pro secondary industry

Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)

Keywords

• Vascular diagnostic devices
• Transcranial doppler systems
• Cardiac output monitors
• Toe pressure measurement
• Ultrasound doppler equipment

Headquarters

HQ city

Soucieu-en-jarrest

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Medical Device Hardware Sales: Sale of medical diagnostic equipment including transcranial Doppler devices (WAKIe, TCD-X), vascular diagnostic systems (ANGIOLYS, BASIC), pocket Dopplers (Microflow S), cardiac output monitors (WAKIe TO), and toe/finger pressure measurement devices (SysToe/SYSTOE).
2. Reusable Probe Sales: Sale of reusable Doppler probes for oesophageal Doppler monitoring. The probes are designed for longevity and reduced environmental impact compared to disposable alternatives.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Atys Medical designs, develops, manufactures, and sells non-invasive diagnostic medical devices using Doppler ultrasound, infrared photoplethysmography (PPG), and pneumoplethysmography (PVR) technologies. The portfolio covers vascular diagnostic testing (ABI, TBI, segmental pressures, PVR/PPG), transcranial Doppler for cerebral blood flow and emboli detection, toe/finger systolic pressure measurement for peripheral arterial disease, oesophageal Doppler cardiac output monitoring, and cerebral autoregulation research software. Products are sold directly to healthcare professionals and institutions globally.

Product overview

Atys Medical is a French manufacturer specializing in non-invasive medical diagnostic devices, with over 30 years of experience. The product portfolio centers on vascular and cerebral blood flow assessment: ANGIOLYS serves as the premium peripheral vascular testing system with modular expandability; the BASIC product line addresses routine vascular diagnostic needs across five models; MICROFLOW S provides pocket Doppler functionality; SYSTOE/SysToe handles toe/finger systolic pressure measurement; WAKIe and TCD-X offer transcranial Doppler capabilities with robotic probes for neurology and neurovascular applications; WAKIe TO provides oesophageal Doppler cardiac output monitoring; and OptiMAP software enables cerebral autoregulation research. Products use Doppler ultrasound, photoplethysmography (PPG), pneumoplethysmography (PVR), and systolic pressure measurement technologies. Applications span angiology, phlebology, diabetic patient monitoring, neurology, anesthesia, and intensive care.

Differentiator

Problem solved

Functional benefit

Brands

• ANGIOLYS: Premium peripheral vascular physiologic testing system for angiology, using Doppler, air cuff and photoplethysmography technology.
• BASIC
• MICROFLOW S
• TCD-X
• SYSTOE / SysToe
• WAKIe
• WAKIe TO

Products and services

• ANGIOLYS Premium peripheral vascular physiologic testing system offering automated testing sequences, simultaneous bilateral measurements, and network connectivity for comprehensive vascular assessment. Uses Doppler, air cuff (PVR), and photoplethysmography (PPG) technologies to record ABI, TBI, segmental pressures, PVR waveforms, Doppler profiles, and venous parameters. Supports up to 12 PVR channels and 10 PPG signals simultaneously.
• BASIC Vascular diagnostic system designed for routine peripheral arterial disease examinations across five models (BASIC 1-3.4). Offers Doppler waveform recording, PPG, PVR, ankle and toe systolic pressure measurement, ABI, TBI, and pulse wave velocity measurement with automatic cuff inflation/deflation and direct printing/network connectivity.
• MICROFLOW S Compact pocket vascular Doppler providing audible blood flow detection with bidirectional flow indication via LEDs. Standard 8 MHz probe (optional 4 MHz), designed for ABI measurements with 9V battery power and automatic shutoff.
• SYSTOE (SysToe) Portable toe and finger systolic pressure measurement device using infrared photoplethysmography (PPG) with a patented algorithm. Enables TBI and FBI measurement for peripheral arterial disease diagnosis, particularly valuable for diabetic patients where ABI is unreliable. Battery-powered, under 0.5 kg. Clinical validation against laser Doppler confirmed on 200 patients at Nimes University Hospital.
• TCD-X First transcranial Doppler Holter device for ambulatory patients. Portable, lightweight, and autonomous with robotic probe that automatically scans orientations and positions on optimal signal. Enables multi-hour recording during daily activities and emboli (HITS) detection for asymptomatic carotid stenosis.
• WAKIe Digital and portable transcranial Doppler device available in three models. Features robotic probes (2 MHz and 1.6 MHz) for automated signal search and stability, M-mode display, emboli detection software, and clinical applications including TIA, stroke, vasospasm, PFO testing, and cerebral autoregulation monitoring. Compact design under 6 kg with battery operation.
• WAKIe TO Oesophageal Doppler cardiac output monitor for continuous non-invasive hemodynamic monitoring during surgery and critical care. Features reusable probe with M-mode display for easy placement, measures blood flow velocity in descending aorta using nomogram calculation, and can pair with a transcranial Doppler in one device.
• OptiMAP Research software for cerebral autoregulation monitoring that runs on WAKIe transcranial Doppler. Provides real-time analysis of intracranial pressure, arterial blood pressure, and MCA mean blood velocity, displaying Mx, PRx, and TOx autoregulation indices similar to ICM+.

Quantifiable outcome

• SysToe can measure blood pressures below 20 mmHg with clinical validation against laser Doppler (200 patients at Nimes University Hospital, published in European Journal of Vascular and Endovascular Surgery)
• +2 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Nimes University HospitalminorOthers · 1 January 2012Clinical validation partnership for SysToe device. Clinical tests on 200 patients performed at Nimes University Hospital demonstrated the reliability of SysToe compared to laser Doppler. The study was published in 'European Journal of Vascular and Endovascular Surgery'.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Deltex Medical: UK-based company that designs, manufactures, and markets oesophageal Doppler cardiac output monitors (CardioQ) for use during surgery and in critical care. Directly competes with Atys Medical's WAKIe TO product in the same hemodynamic monitoring category with similar technology and clinical use cases.
• Compumedics (DWL): Compumedics, through its Doppler product line (formerly DWL), manufactures transcranial Doppler systems for neurovascular diagnostics including emboli detection and cerebral blood flow monitoring. Directly competes with Atys Medical's WAKIe and TCD-X in transcranial Doppler applications.
• Huntleigh Diagnostics: Part of the Arjo group, Huntleigh manufactures vascular Doppler and ABI/TBI measurement systems used in peripheral arterial disease screening. Directly competes with Atys Medical's ANGIOLYS, BASIC, and MICROFLOW S products in routine vascular diagnostics.
• Hadeco: Japanese manufacturer of bidirectional Doppler and vascular diagnostic equipment including handheld Dopplers and PPG-based pressure measurement systems. Directly competes with Atys Medical's pocket Doppler and toe pressure product lines globally.

Emerging players

• Viasonix: Israel-based company developing transcranial Doppler and peripheral vascular diagnostic ultrasound systems. Overlaps with Atys Medical's vascular Doppler and TCD product lines, particularly in research and clinical neurovascular applications.
• USCOM: Australian developer of non-invasive cardiac output monitors (USCOM 1A) using Doppler ultrasound technology in similar clinical use cases as Atys Medical's WAKIe TO, particularly in critical care and emergency settings.
• Moor Instruments: UK-based manufacturer of laser Doppler perfusion monitoring and microvascular imaging systems. Provides complementary technology to Atys Medical's PPG-based blood flow measurement, with overlap in microcirculation assessment research.

Broad incumbents

• Natus Medical: Broadly diversified neurodiagnostics and newborn care company whose neurology portfolio (including TCD and emboli detection products) overlaps with Atys Medical's WAKIe and TCD-X, though Natus operates across many adjacent neurology segments as a larger incumbent.
• Edwards Lifesciences: Global leader in hemodynamic monitoring (FloTrac, ClearSight, HemoSphere) used in operating rooms and ICUs. Competes with Atys Medical's WAKIe TO in cardiac output monitoring but operates as a much larger incumbent with broader critical-care offerings.
• Philips Healthcare: Global medtech incumbent whose patient monitoring and ultrasound portfolios (including TCD and vascular diagnostic capabilities) intersect with several of Atys Medical's product categories, though Philips operates at much greater scale and broader scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/atys-medical

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Atys Medical